Quality of life with palbociclib plus fulvestrant in previously treated hormone receptor-positive, HER2-negative metastatic breast cancer: patient-reported outcomes from the PALOMA-3 trial - Harbeck, N; Iyer, S; Turner, N (Ann Oncol, 2016)